IPO Watch: Best New Stocks of Q3

Oct 1, 2015, 12:40 pm EST
IPO Watch: Best New Stocks of Q3

Whenever there is a spike in volatility, the market for new stocks always gets hit particularly hard. This time around has been no different. For the most part, the initial public offering market has gotten off to a very slow start.

But this does not mean that things are hopeless.

Keep in mind that conditions can change quickly — and the result can spike interest in new stocks. What’s more, for the third quarter, there are a variety of large, high-quality companies prepping IPOs. Read 

Ferrari IPO Could Launch This Friday

Sep 30, 2015, 12:30 pm EST

Fiat Chrysler’s (FCAU) Ferrari IPO could happen as early as this Friday after a year of talk about it. Source: Auto Car India

News that the Ferrari IPO, which could be worth $1 billion, could occur as soon as Friday comes from unnamed sources. It’s also possible that pricing for the IPO will start in mid-October. The IPO was first heard of in October 2014 after a Securities and Exchange Commission filing, reports Business Insider.

The new Ferrari IPO will be for a company that isn’t just focused on cars, but will also include luxury goods. The shares will be traded on the New York Stock Exchange alongside Fiat Chrysler shares. Legally, the company can’t start its IPO until Oct. 13 due to the recent merger of Fiat and Chrysler, NBC News notes. Read 

This Week’s New Stocks: Lots of Biotechs, Unfortunately

Sep 28, 2015, 12:17 pm EST
This Week’s New Stocks: Lots of Biotechs, Unfortunately

The good news is that there are plenty of new stocks on deck. However, the bad news is that most of them are biotech operators. Source: ©iStock.com/pichet_w

Of course, the sector has plunged into bear market territory, with the ProShares Ultra Nasdaq Biotechnology ETF (BIB) off more than 30% since July.

As should be no surprise, the smaller operators have taken the biggest hits. And this certainly will make the environment extremely tough for this week’s biotech IPOs. Read 

Upcoming IPOs: The Good, The Bad and The Ugly

Sep 21, 2015, 1:03 pm EST
Upcoming IPOs: The Good, The Bad and The Ugly

Market corrections are always poison for initial public offerings. So it should be no surprise that there have only been a handful of IPOs so far in September. But this should be a good thing, as Wall Street will focus mostly on quality deals. Source: ©iStock.com/pichet_w

Yet, this does not mean you can buy just about anything. Let’s face it, tech IPOs are likely to continue to lag, especially as investors want to see more balance of growth and profitability.

“For those companies that do navigate the choppy IPO waters, they will be held to a higher standard and best be prepared to deliver results,” said Ron Heinz, who is a managing partner at Signal Peak Ventures: Read 

Can Planet Fitness Put Up a Run for Your Money? (PLNT)

Sep 3, 2015, 11:17 am EST
Can Planet Fitness Put Up a Run for Your Money? (PLNT)

Timing is everything for an initial public offering, which gym operator Planet Fitness (PLNT) learned the hard way.

When the company launched its IPO in early August, it was on the heels of the markets move into a brutal correction. So on the debut of the deal, PLNT stock posted a return of zero and quickly fell from $16 to $13.65.

But as the market turned, so did Planet Fitness. As of now, PLNT stock is trading at about $18.70. Read 

Should You Buy Fitbit Stock? 3 Pros, 3 Cons (FIT)

Sep 1, 2015, 2:36 pm EST
Should You Buy Fitbit Stock? 3 Pros, 3 Cons (FIT)

Fitbit (FIT), the maker of a highly popular line of fitness trackers, got off to a roaring start with its IPO back in mid-June. The stock soared by 48% on its first day of trading after the company boosted the number of shares issued and the price range.

But since then, things have cooled down as the equities markets have gotten much more volatile. Fitbit stock is off about 35% from its high.

Despite this, the company continues to grow at a torrid pace. In the latest quarter, revenues spiked by 253% to $400 million and the adjusted EBITDA came to $86.2 million. For the period, FIT sold about 4.5 million devices, up from 1.72 million in the same period a year ago. Read 

1 2 3 4 5 237